Actively Recruiting
Observational Study of Chronic Hepatitis B Virus Infection in Jiangsu Tracking Long-Term Outcomes and Risk Factors
Led by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · Updated on 2017-03-31
20000
Participants Needed
6
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Chronic hepatitis B virus HBV infection is a major global health issue that can lead to serious liver problems such as cirrhosis, liver cancer, and death. This observational study aims to gather detailed information from a broad group of Chinese patients with chronic HBV infection to better understand the factors that influence disease outcomes. The study involves creating a comprehensive database of clinical, epidemiological, biological, virological, immunologic, and treatment-related data from patients with chronic HBV infection. There are no drug interventions instead, participants are monitored as part of this long-term cohort. Participants will be followed over many years, with researchers tracking outcomes like loss of hepatitis B antigens, development of cirrhosis, liver failure, liver cancer, and mortality. Regular assessments will collect relevant health information to help identify the factors linked to disease progression. The study is planned to continue until 2030, providing extensive long-term data on chronic HBV infection.
CONDITIONS
Brief Title
"Real-life" Cohort Study on Patients With Chronic HBV Infection in Jiangsu
Research Team
C
Chao Wu, M.D., Ph.D
R
Rui Huang, M.D., Ph.D.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
